The Washington Post reports:
A Food and Drug Administration panel of outside experts is meeting Thursday to review the Moderna coronavirus vaccine. The panel is discussing the vaccine’s safety and efficacy and, if all goes as expected, the shots could get emergency clearance as soon as Friday.
The FDA, in a report Tuesday, confirmed that in Moderna’s clinical trial, the two-shot regimen was 94 percent effective at preventing illness and was particularly effective against severe disease. The vaccine has not caused major safety problems, the report confirmed.
Read the full article.
A panel of outside advisers to the U.S. Food and Drug Administration is expected to endorse emergency use of Moderna Inc’s coronavirus vaccine during a meeting on Thursday, as the nation prepares to roll out a second vaccine. https://t.co/pwGyuGy3PC
— Reuters Health (@Reuters_Health) December 17, 2020